Hajer Elkout

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Inferior Vena Cava

Electronic Health Record

Top Venues

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Mansour Tobaiqy, Hajer Elkout
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. International journal of clinical pharmacy (2024)
Mansour Tobaiqy, Hajer Elkout
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. International journal of clinical pharmacy 46 (2) (2024)
Mansour Tobaiqy, Hajer Elkout
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. International journal of clinical pharmacy 46 (2) (2024)
Mansour Tobaiqy, Hajer Elkout
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database. International journal of clinical pharmacy 46 (2) (2024)
Mansour Tobaiqy, Kathrine Maclure, Hajer Elkout, Derek Stewart
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database. Vaccines 9 (11) (2021)